Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00784316Phase 4Completed
Phase 4, randomised, double-blind trial of metoprolol and amiodarone in Atrial fibrillation (AFib), sponsored by Kuopio University Hospital. Primary endpoint: Incidence of Atrial Fibrillation at 48 hours. Started Aug 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00784316.